Albendazole 400 mg: Clinical Trials

5 trials of Albendazole 400 mg, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 2 not yet recruiting, 1 recruiting. 2 Not applicable, 1 Phase 1, 1 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable2Completed 1, Recruiting 1
Phase 11Completed 1
Phase 21Not yet recruiting 1
Phase 31Not yet recruiting 1

Follow Albendazole 400 mg: new trials by email Literature Review of Albendazole 400 mg trials Research Report on Albendazole 400 mg

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy and Safety of a Single Dose of Emodepside Compared to a Single Dose of Albendazole in Adolescents and Adults Infected With Trichuris Incognita
Emodepside, Albendazole 400 mg - Trichuris Infection
Phase 2Not yet recruitingJennifer Keiser1002026-11-152026-08-14
Combination Therapies for Trichuris Trichiura Infection in Schoolchildren in Honduras
Placebo, Albendazole 400 mg, Albendazole Plus Ivermectin - Trichuriasis, Strongyloidiasis
Phase 3Not yet recruitingMundo Sano Foundation3682026-11-012026-06-23
Expanding Access to Preventive Chemotherapy Among Mobile and Migrant Populations
Modified Mass Administration of Medicines Strategy, Albendazole 400 mg, Praziquantel 40 mg/kg - Onchocerciasis (River Blindness), Schistosomiasis
Not applicableRecruitingUwemedimo Friday Ekpo57602026-07-012026-07-16
Community Health Education and Hygiene Promotion Added to Deworming Among Ethnic Khmer Children in Vietnam
Albendazole 400 mg, Community Health Education and Hygiene Promotion - Soil-transmitted Helminth Infections
Not applicableCompletedCan Tho University of Medicine and Pharmacy7042025-07-012026-10-02
Bioequivalence Study Between Two Albendazole 400 mg Tablets in Healthy Adult Participants Under Fed Conditions
Albendazole IP 400 mg, Albendazole 400 mg - Intestinal Diseases
Phase 1CompletedGlaxoSmithKline702023-08-212025-01-27

Conditions studied

Trichuriasis (2)  ·  Ancylostomiasis (1)  ·  Ascariasis (1)  ·  Elephantiasis, Filarial (1)  ·  Health Education (1)  ·  Hookworm Infections (1)  ·  Infections (1)  ·  Intestinal Diseases (1)  ·  Neglected Diseases (1)  ·  Onchocerciasis (1)  ·  Onchocerciasis, Ocular (1)  ·  Schistosomiasis (1)  ·  Strongyloidiasis (1)

Sponsors

Can Tho University of Medicine and Pharmacy (1)  ·  GlaxoSmithKline (1)  ·  Jennifer Keiser (1)  ·  Mundo Sano Foundation (1)  ·  Uwemedimo Friday Ekpo (1)

Countries

Honduras (1)  ·  India (1)  ·  Nigeria (1)  ·  Vietnam (1)

Top investigators

Alejandro Javier Krolewiecki, PhD, MD (1)  ·  Gabriela Matamoros, PhD, MSc, BSc (1)  ·  Hammed Mogaji, PhD (1)  ·  Uwem Ekpo, PhD (1)